Lung cancer screening: advancing early detection and improving outcomes

Abstract Lung cancer remains the leading cause of cancer death worldwide, mainly due to late diagnoses. While low-dose computed tomography (LDCT) screening reduces mortality in high-risk groups, false positives and low nodule specificity remain major challenges. High nodule prevalence even in nonsmo...

Full description

Saved in:
Bibliographic Details
Main Author: Geertruida H. de Bock
Format: Article
Language:English
Published: Springer 2025-08-01
Series:Holistic Integrative Oncology
Subjects:
Online Access:https://doi.org/10.1007/s44178-025-00188-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388729935855616
author Geertruida H. de Bock
author_facet Geertruida H. de Bock
author_sort Geertruida H. de Bock
collection DOAJ
description Abstract Lung cancer remains the leading cause of cancer death worldwide, mainly due to late diagnoses. While low-dose computed tomography (LDCT) screening reduces mortality in high-risk groups, false positives and low nodule specificity remain major challenges. High nodule prevalence even in nonsmokers further highlights the need for better risk stratification. Improved screening may be achieved through refined nodule assessment, sex-specific models, and emerging biomarkers like blood-based assays. Integrating these tools can enhance accuracy and reduce harms. Continued efforts to promote smoking cessation and improve air quality are also crucial.
format Article
id doaj-art-cf4097a68ea14377a9bc918b3d5f1a42
institution Kabale University
issn 2731-4529
language English
publishDate 2025-08-01
publisher Springer
record_format Article
series Holistic Integrative Oncology
spelling doaj-art-cf4097a68ea14377a9bc918b3d5f1a422025-08-20T03:42:10ZengSpringerHolistic Integrative Oncology2731-45292025-08-01411310.1007/s44178-025-00188-yLung cancer screening: advancing early detection and improving outcomesGeertruida H. de Bock0Department of Epidemiology, University of Groningen, University Medical Center GroningenAbstract Lung cancer remains the leading cause of cancer death worldwide, mainly due to late diagnoses. While low-dose computed tomography (LDCT) screening reduces mortality in high-risk groups, false positives and low nodule specificity remain major challenges. High nodule prevalence even in nonsmokers further highlights the need for better risk stratification. Improved screening may be achieved through refined nodule assessment, sex-specific models, and emerging biomarkers like blood-based assays. Integrating these tools can enhance accuracy and reduce harms. Continued efforts to promote smoking cessation and improve air quality are also crucial.https://doi.org/10.1007/s44178-025-00188-yLung cancerPopulation-based screeningRisk stratificationSmoking cessation
spellingShingle Geertruida H. de Bock
Lung cancer screening: advancing early detection and improving outcomes
Holistic Integrative Oncology
Lung cancer
Population-based screening
Risk stratification
Smoking cessation
title Lung cancer screening: advancing early detection and improving outcomes
title_full Lung cancer screening: advancing early detection and improving outcomes
title_fullStr Lung cancer screening: advancing early detection and improving outcomes
title_full_unstemmed Lung cancer screening: advancing early detection and improving outcomes
title_short Lung cancer screening: advancing early detection and improving outcomes
title_sort lung cancer screening advancing early detection and improving outcomes
topic Lung cancer
Population-based screening
Risk stratification
Smoking cessation
url https://doi.org/10.1007/s44178-025-00188-y
work_keys_str_mv AT geertruidahdebock lungcancerscreeningadvancingearlydetectionandimprovingoutcomes